SBIR Phase II: Bioengineered Next-Generation Tympanostomy Tubes to Improve Patient Outcome — NSF Award to MATERIALIZE BIO, INC. (M
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to improve outcomes for ear tube surgery, one of the most common surgical procedures performed in children, while establishing a scalable manufacturing approach for medical implants made from natural materials.
| Award title | SBIR Phase II: Bioengineered Next-Generation Tympanostomy Tubes to Improve Patient Outcome |
|---|---|
| Award ID | 2604767 |
| Awardee | MATERIALIZE BIO, INC. |
| City | SOMERVILLE |
| State | MA |
| Amount obligated | $1,250,000 |
| Principal investigator | Joanna Xylas |
| Program | SBIR Phase II |
| Start date | 06/15/2026 |
| Abstract | The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to improve outcomes for ear tube surgery, one of the most common surgical procedures performed in children, while establishing a scalable manufacturing approach for medical implants made from natural materials. Approximately one million patients in the United States receive ear tubes each year, yet current devices rely on permanent plastics or metals that can cause complications, require |
| Source | NSF Awards |
$799/mo
Try NSFGrants →